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Abstract
Acetamide derivatives and one pyridone derivative were prepared. The structure of the synthesized
compounds was verified through elemental analyses, 1H -NMR and 13C- NMR, IR spectra. The NQO1
inducer activity of the synthesized compounds was evaluated using a quantitative bioassay in Hepa1c1c7
murine hepatoma cells. The acetamide derivatives showed weak activity, with the 3-ethylphenyl being
more potent than the 2-ethylphenyl derivative. The pyridone derivative was inactive.
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Introduction
The antioxidant activity is related with compounds competent
of protecting a biological system against the potential harmful
effects of oxidative processes. The antioxidant components in
the last years have received enlarged care from medical
researchers and nutritionists for their potential activities in
stopping cancer, cardiovascular disorders, as well as aging [1].
Acetamide derivatives have been reported to possess a wide
variety of important biological properties such as anti-malarial
[2], antimicrobial [3-5], anti-proliferative [6], inhibitors of
Pim-1 kinase [7], anti-inflammatory [8], anticonvulsant [9],
antidyslipidemic, antioxidant [10], anti-HIV [11]. A large
number of acetamide derivatives have been reported to show
potential anticancer activity in vitro and in vivo [12-14]. In
addition compounds containing heteroaromatic rings regularly
are playing very important role as supports of bioactive
substances. It is known that the pyridone and its derivatives are
among the most popular N-heteroaromatic compounds
integrated into the structures of many pharmaceutical
compounds and their structural units occur in several
molecules showing diverse biological activities [15-20].
Recently, a series of pyridine derivatives were reported to
possess antioxidant, anticancer and angiotensin-I-converting
enzyme (ACE-I) inhibitory activity [21-23]. As part of our
continuing interest in this area, in the present work we
synthesised acetamide derivatives (3, 5), and, dihydropyridine
derivative (6) to evaluated their cytoprotective activity. We
used induction of the cytoprotective enzyme NAD(P)H:
quinone oxidoreductase 1 (NQO1) as a measure of
cytoprotective activity.
Experimental
The melting points (°C, uncorrected) are determined in open
capillaries on a Gallenkemp melting point apparatus (Sanyo
Gallenkemp, Southborough, UK). Pre-coated with Silica gel
plates (silica gel, 60 G F 254, 0.25 mm, Merck, Germany) are
used for TLC, methanol/dichloromethane (0.5: 9.5 mL)
mixture was used as a developing solvent system. IR spectra
were recorded in KBr discs using IR-Shimadzu spectrometer
(Shimadzu, Tokyo, Japan). NMR spectra in (DMSO-d6) were
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recorded on Bruker Ac-500 ultra-shield NMR spectrometer
(Bruker, Flawil, Switzerland, δ ppm) at 500 MHz, using TMS
as internal standard. Elemental analyses were performed on
Carlo Erba 1108 Elemental Analyzer (Heraeus, Hanau,
Germany). All compounds were within ± 0.4 % of the
theoretical values.
2-Cyano-N-(2-ethylphenyl) acetamide (3)
A mixture of 2-ethyl aniline 1 (1.21 g, 0.01 mol) and ethyl
cyanoacetate 2 (1.13 g, 0.01 mol) was refluxed for 2 h,
concentrated and cooled. The obtained solid was filtered
andcrystallized from benzene/ether (3:2) give compound 3
[24].
Yield, 80 %, m.p. 130-132 °C; IR (KBr, max, cm-1): 3180
(NH), 2255 (CN), 1703 (CO). 1H- NMR spectrum of 3 in
(DMSO-d6) δ : 1.09 [t, 3H, CH3], 2.23 [q, 2H, CH2], 3.85 [s,
2H, CH2CN], 7.3-7.5 [m, 4H, Ar-H], 9.45 [s, 1H, NH,
exchangeable with D2O], “Anal. Calculated; for C11H12N2O
C, 70.21; H, 6.38, 14.89; found: Carbon, 70.50; Hydrogen,
6.10; Nitrogen, 14.60.”
2- Cyano-N-(3-ethylphenyl) acetamide (5)
A mixture of 3-ethylaniline 4 (1.21 g, 0.01 mol) and ethyl
cyanoacetate 2 (1.13 g, 0.01 mol) was fused at 220 °C (for 3
h). The concentrated reaction mixture was cooled. The gotten
product was crystallized from the etahanol to afford compound
5 [25] (Scheme 1). The yield as 88 %, m. p. 86-88 °C; IR (KBr,
nmax, cm-1): 3317 (NH), 3100 (CH. arom.), 2960, 2870 (CH
aliph.), 2260 (CºN), 1670 (C=O). 1H NMR spectrum of 3 in
(DMSO-d6)δ : 1.2 [t, 3H, CH3], 2.6 [q, 2H, CH2], 3.6 [s, 2H,
CH2], 4.2 [s, 1H, NH, exchangeable with D2O], 7.03-7.7 [m,4H, Ar-H]. “Anal. Calcd; for C11H12N2O: C, 70.21; H, 6.38,
14.89; found: C, 70.50; H, 6.10; N, 14.60.
1- (3-Ethylphenyl)-4, 6-dimethyl-2-oxo-1, 2-
dihydropyridine-3 - carbonitrile (6)
Interaction of component 3 (1.88 g, 0.01 mol) with
acetylacetone (1.00 g, 0.01 mol) in ethyl alcohol (50 mL),
piperidine (0.5 mL) was refluxed for 5 h. The reaction mixture
was triturated with ethyl alcohol and the obtained solid was re-
crystallized from dioxane to yield compound 6 [26] (Scheme
1). Yield: 86%. M.p.: 198200 °C. IR (KBr, ν, cm–1): 3100 (CH
arom.), 2931, 2872 (CH aliph.), 2210 (C≡N), 1660 (C=O). 1H
NMR (300 MHz, DMSOd6,δ, ppm): 1.2 (t, 3H, CH3, J=0.66
Hz), 1.5 (2s, 6H, 2CH3), 2.6 (q, 2H, CH2, J=0.66 Hz), 5.6 (s,
1H, CH pyridine), 7.27.7 (m, 4H, ArH). Anal. calcd. for
C16H16N2O: C, 76.16; H, 6.39; N, 11.10. Found: C, 76.50; H,
6.70; N, 11.40%”.
Biological assay
The NQO1 inducer activity was determined using a
quantitative microtiter plate bioassay [27,28]. Compounds
were prepared as stock solutions in DMSO, and then were
diluted in the cell culture medium 1:1000. The final
concentration of the solvent in the medium of the growing cells
was 0.1% (v/v). Each compound was tested at eight replicates
of 8 serial dilutions. The murine Hepa1c1c7 cell line was
maintained at 37°C, 5% CO2, in α-MEM supplemented with
10% (v/v) fetal bovine serum that had been heat-and charcoal-
inactivated. Cells (104 per well) were plated in 96-well plates,
and 24 h later, they were exposed to the compounds in fresh
medium for a further 48 h. The cell culture medium was then
removed; cells were washed 3 times with PBS, and lysed for
30 min at 25°C in digitonin (0.1 g/L, pH 7.8). To measure the
enzyme activity of NQO1 the quinone menadione was used as
a substrate. Protein concentrations were determined by the
BCA assay (Thermo Scientific), and the values were used to
calculate the specific NQO1 activity (Table 1 and Figure 1).
Table 1. NQO1 inducer activity of acetamide and pyridine-3-
carbonitrile derivatives.
Compounds Induction Magnitude (Fold)
“2-Cyano-N-(2-ethylphenyl) acetamide (3)” 1.2
“2-Cyano-N-(3-ethylphenyl) acetamide (5)” 1.65
“1-(3-Ethylphenyl)-4,6-dimethyl-2-oxo-1,2-
dihydropyridine- 3-carbonitrile (6)”
Inactive
Figure 1. Dose-response of NQO1 inducer activity of acetamide and
pyridine-3-carbonitrile derivatives.
Results and Discussion
The aim of this work was to design and synthesis of a series of
acetamides (3, 5) and pyridine (6) (Scheme 1) and evaluation
of their potential NQO1 inducer activity. Interaction of 2-ethyl
1 or 3-ethylaniline 4 with ethyl cyanoacetate 2 furnished the
corresponding acetamide derivatives 3 and 5, respectively. The
structure of compounds 3 and 5 was proved in the basis of
elemental analysis and spectral data. The corresponding
pyridine derivative 6 was obtained via reaction of compound 5
with acetylacetone in the presence of a catalytic amount of
piperedine. The structure of compound 6 was established by
elemental analysis, spectral data.
Ghorab/Shahat/Alsaid/Higgins/Dinkova-Kostova/Naser
1046 Biomed Res- India 2016 Volume 27 Issue 4
NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1) is a
cytoprotective enzyme which is activated by electrophilic
compounds via the Keap1/Nrf2 pathway [29]. Numerous
compounds which have been shown to induce NQO1 have
been subsequently found to the broadly cytoprotective and to
effectively inhibit tumor formation in animal models [30,31].
We found that the acetamide derivatives have weak NQO1
inducer activity. The 3-ethylphenyl (5) is more potent than the
2-ethylphenyl (3) derivative. The pyridone derivative (6) is
inactive.
Scheme 1. Formation of acetamide and pyridone derivatives 3,5,6.
Conclusion
The present study objective to synthesize and evaluate the
potential anticancer activities of some acetamide and pyridine
derivatives. The acetamide derivative (5) was the most active.
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